Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trialAtul Malhotra, Mathijs C. Bunck, Terri E. Weaver et al.|Contemporary Clinical Trials|2024Cited by 78
Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trialVincent C. Marconi, E. Wesley Ely, Athimalaipet V Ramanan et al.|medRxiv|2021Cited by 36